Latest News and Press Releases

GEREGLEMENTEERDE INFORMATIE Bijlage Communiqué 260512NL_Dividende ...

ALBION CROWN VCT PLC LEI Code 213800SYIQPA3L3T1Q68                                                                                                                                       DIRECTORATE...

Luxembourg – 12 May 2026 – Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced the election of John Evans to the Board of Directors of Subsea 7 S.A. at the 2026 annual general meeting of...

Luxembourg – 12 May 2026 - Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY, the Company) today announced that, at the 2026 annual general meeting of shareholders (AGM) on 12 May 2026, all resolutions were...

Announcement no. 9-2026 12 May 2026   Martin Frandsen Tobberup, Group Executive Director and CDO, on the Group’s performance in Q1 2026: ” We delivered an improved operating result, which was...

Selskabsmeddelelse nr. 9-2026 12. maj 2026   North Medias ordførende koncerndirektør Martin Frandsen Tobberup siger om udviklingen i 1. kvartal 2026: ”Vi leverede et forbedret driftsresultat, som...

FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE...

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to...

NEW YORK, 12 mai 2026 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), société de biotechnologie de stade clinique qui utilise sa plateforme pionnière d’édition du génome pour...

8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY...